Antibody Reagents
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
49
NCT04250597
Study of GNX102 in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 29, 2020
Completion: Jul 26, 2023
NCT04798235
First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis
Phase: Phase 1/2
Role: Collaborator
Start: Mar 12, 2021
Completion: Mar 12, 2027
Loading map...